Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cannabis Use Reduction in ADHD
NCT03481959Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in cannabis use disorder (CUD), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2019; status: terminated.
02
Drugs
methylphenidate
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03481959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03481959.